IRIS Accounts Production v24.3.2.46 SC222920 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC2229202022-12-31SC2229202023-12-31SC2229202023-01-012023-12-31SC2229202021-12-31SC2229202022-01-012022-12-31SC2229202022-12-31SC222920ns15:Scotland2023-01-012023-12-31SC222920ns14:PoundSterling2023-01-012023-12-31SC222920ns10:Director12023-01-012023-12-31SC222920ns10:PrivateLimitedCompanyLtd2023-01-012023-12-31SC222920ns10:SmallEntities2023-01-012023-12-31SC222920ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-31SC222920ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-31SC222920ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-31SC222920ns10:FullAccounts2023-01-012023-12-31SC22292012023-01-012023-12-31SC222920ns10:Director32023-01-012023-12-31SC222920ns10:CompanySecretary12023-01-012023-12-31SC222920ns10:RegisteredOffice2023-01-012023-12-31SC222920ns5:CurrentFinancialInstruments2023-12-31SC222920ns5:CurrentFinancialInstruments2022-12-31SC222920ns5:ShareCapital2023-12-31SC222920ns5:ShareCapital2022-12-31SC222920ns5:RetainedEarningsAccumulatedLosses2023-12-31SC222920ns5:RetainedEarningsAccumulatedLosses2022-12-31SC222920ns5:NetGoodwill2023-01-012023-12-31SC222920ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-31SC222920ns5:PlantMachinery2023-01-012023-12-31SC222920ns5:FurnitureFittings2023-01-012023-12-31SC222920ns5:MotorVehicles2023-01-012023-12-31SC222920ns5:ComputerEquipment2023-01-012023-12-31SC222920ns5:NetGoodwill2022-12-31SC222920ns5:NetGoodwill2023-12-31SC222920ns5:NetGoodwill2022-12-31SC222920ns5:LeaseholdImprovements2022-12-31SC222920ns5:PlantMachinery2022-12-31SC222920ns5:FurnitureFittings2022-12-31SC222920ns5:LeaseholdImprovements2023-01-012023-12-31SC222920ns5:LeaseholdImprovements2023-12-31SC222920ns5:PlantMachinery2023-12-31SC222920ns5:FurnitureFittings2023-12-31SC222920ns5:LeaseholdImprovements2022-12-31SC222920ns5:PlantMachinery2022-12-31SC222920ns5:FurnitureFittings2022-12-31SC222920ns5:MotorVehicles2022-12-31SC222920ns5:ComputerEquipment2022-12-31SC222920ns5:MotorVehicles2023-12-31SC222920ns5:ComputerEquipment2023-12-31SC222920ns5:MotorVehicles2022-12-31SC222920ns5:ComputerEquipment2022-12-31SC222920ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31SC222920ns5:WithinOneYearns5:CurrentFinancialInstruments2022-12-31SC2229201ns10:Director12022-12-31SC2229201ns10:Director12021-12-31SC2229201ns10:Director12023-01-012023-12-31SC2229201ns10:Director12022-01-012022-12-31SC2229201ns10:Director12023-12-31SC2229201ns10:Director12022-12-31
REGISTERED NUMBER: SC222920 (Scotland)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

Arran Pharmacy Limited

Arran Pharmacy Limited (Registered number: SC222920)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


Arran Pharmacy Limited

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mr D Thompson
Miss D L Thompson





SECRETARY: Miss D L Thompson





REGISTERED OFFICE: Pavilion 2
3 Dava Street
Broomloan Road
Glasgow
G51 2JA





REGISTERED NUMBER: SC222920 (Scotland)





ACCOUNTANTS: Burgoyne Carey
Chartered Accountants
Pavilion 2
3 Dava Street
Broomloan Road
Glasgow
G51 2JA

Arran Pharmacy Limited (Registered number: SC222920)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 191,440 1,167
191,440 1,167

CURRENT ASSETS
Stocks 118,458 103,890
Debtors 6 245,597 246,485
Cash at bank and in hand 51,972 214,447
416,027 564,822
CREDITORS
Amounts falling due within one year 7 188,713 207,539
NET CURRENT ASSETS 227,314 357,283
TOTAL ASSETS LESS CURRENT
LIABILITIES

418,754

358,450

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 418,654 358,350
SHAREHOLDERS' FUNDS 418,754 358,450

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Arran Pharmacy Limited (Registered number: SC222920)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 January 2025 and were signed on its behalf by:





Mr D Thompson - Director


Arran Pharmacy Limited (Registered number: SC222920)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

Arran Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover represents prescription income from the NHS and over-the-counter sales.

GOODWILL
Goodwill, being the amount paid in connection with the acquisition of businesses in 2002 and 2005, is being amortised evenly over its estimated useful life of 10 years.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Arran Pharmacy Limited (Registered number: SC222920)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

2. ACCOUNTING POLICIES - continued

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2022 - 14 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2023
and 31 December 2023 228,938
AMORTISATION
At 1 January 2023
and 31 December 2023 228,938
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 -

5. TANGIBLE FIXED ASSETS
Fixtures
Tenants and
improvements Equipment fittings
£    £    £   
COST
At 1 January 2023 - 16,874 29,619
Additions 191,436 - -
At 31 December 2023 191,436 16,874 29,619
DEPRECIATION
At 1 January 2023 - 16,873 29,618
Charge for year - - -
At 31 December 2023 - 16,873 29,618
NET BOOK VALUE
At 31 December 2023 191,436 1 1
At 31 December 2022 - 1 1

Arran Pharmacy Limited (Registered number: SC222920)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

5. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 January 2023 10,000 5,268 61,761
Additions - - 191,436
At 31 December 2023 10,000 5,268 253,197
DEPRECIATION
At 1 January 2023 8,836 5,267 60,594
Charge for year 1,163 - 1,163
At 31 December 2023 9,999 5,267 61,757
NET BOOK VALUE
At 31 December 2023 1 1 191,440
At 31 December 2022 1,164 1 1,167

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 65,897 99,978
Other debtors 35,000 -
VAT 138,550 138,607
Prepayments 6,150 7,900
245,597 246,485

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 93,112 155,956
Tax (9,266 ) (8,953 )
Social security and other taxes 81,133 54,859
Pensions 1,387 1,406
Directors' current accounts 18,457 282
Accrued expenses 3,890 3,989
188,713 207,539

Arran Pharmacy Limited (Registered number: SC222920)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
Mr D Thompson
Balance outstanding at start of year (282 ) (282 )
Amounts advanced 1,825 -
Amounts repaid (20,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (18,457 ) (282 )